Publications by authors named "Ute Manning"

4Publications

Pyrazoloheteroaryls: novel p38alpha MAP kinase inhibiting scaffolds with oral activity.

Authors:
Laszlo Revesz Ernst Blum Franco E Di Padova Thomas Buhl Roland Feifel Hermann Gram Peter Hiestand Ute Manning Ulf Neumann Gerard Rucklin

Bioorg Med Chem Lett 2006 Jan 24;16(2):262-6. Epub 2005 Oct 24.

Novartis Institutes for BioMedical Research, Global Discovery Chemistry, CH-4002 Basel, Switzerland.

View Article and Find Full Text PDF
January 2006

SAR of benzoylpyridines and benzophenones as p38alpha MAP kinase inhibitors with oral activity.

Authors:
Laszlo Revesz Ernst Blum Franco E Di Padova Thomas Buhl Roland Feifel Hermann Gram Peter Hiestand Ute Manning Gerard Rucklin

Bioorg Med Chem Lett 2004 Jul;14(13):3601-5

Novartis Institutes for BioMedical Research, Arthritis and Bone Metabolism, CH-4002 Basel, Switzerland.

View Article and Find Full Text PDF
July 2004

Novel p38 inhibitors with potent oral efficacy in several models of rheumatoid arthritis.

Authors:
Laszlo Revesz Ernst Blum Franco E Di Padova Thomas Buhl Roland Feifel Hermann Gram Peter Hiestand Ute Manning Gerard Rucklin

Bioorg Med Chem Lett 2004 Jul;14(13):3595-9

Novartis Institutes for BioMedical Research, Arthritis & Bone Metabolism, CH-4002 Basel, Switzerland.

View Article and Find Full Text PDF
July 2004

SAR of 2,6-diamino-3,5-difluoropyridinyl substituted heterocycles as novel p38MAP kinase inhibitors.

Authors:
Laszlo Revesz Franco E Di Padova Thomas Buhl Roland Feifel Hermann Gram Peter Hiestand Ute Manning Romain Wolf Alfred G Zimmerlin

Bioorg Med Chem Lett 2002 Aug;12(16):2109-12

Arthritis and Bone Research, Novartis Pharma AG, CH-4002, Basel, Switzerland.

View Article and Find Full Text PDF
August 2002